Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.

Boeri M, Milione M, Proto C, Signorelli D, Russo GL, Galeone C, Verri C, Mensah M, Centonze G, Martinetti A, Sottotetti E, Pastorino U, Garassino MC, Sozzi G.

Clin Cancer Res. 2019 Jan 7. doi: 10.1158/1078-0432.CCR-18-1981. [Epub ahead of print]

PMID:
30617131
2.

Activity of EGFR TKIs in Caucasian Patients With NSCLC Harboring Potentially Sensitive Uncommon EGFR Mutations.

Passaro A, Prelaj A, Bonanno L, Tiseo M, Tuzi A, Proto C, Chiari R, Rocco D, Genova C, Sini C, Cortinovis D, Pilotto S, Landi L, Bennati C, Camerini A, Toschi L, Putzu C, Cerea G, Spitaleri G, Cappuzzo F, de Marinis F.

Clin Lung Cancer. 2018 Nov 20. pii: S1525-7304(18)30301-2. doi: 10.1016/j.cllc.2018.11.005. [Epub ahead of print]

PMID:
30563752
3.

Low Baseline Serum Sodium Concentration Is Associated with Poor Clinical Outcomes in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy.

Fucà G, Galli G, Poggi M, Lo Russo G, Proto C, Imbimbo M, Vitali M, Ganzinelli M, Lanti C, Molino G, Stangoni F, Zilembo N, de Braud F, Garassino MC, Signorelli D.

Target Oncol. 2018 Dec;13(6):795-800. doi: 10.1007/s11523-018-0599-5.

PMID:
30306460
4.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC.

Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11.

PMID:
30206165
5.

Use of nivolumab in elderly patients with advanced squamous non-small-cell lung cancer: results from the Italian cohort of an expanded access programme.

Grossi F, Crinò L, Logroscino A, Canova S, Delmonte A, Melotti B, Proto C, Gelibter A, Cappuzzo F, Turci D, Gamucci T, Antonelli P, Marchetti P, Santoro A, Giusti S, Di Costanzo F, Giustini L, Del Conte A, Livi L, Giannarelli D, de Marinis F.

Eur J Cancer. 2018 Sep;100:126-134. doi: 10.1016/j.ejca.2018.05.015. Epub 2018 Jul 13.

PMID:
30014881
6.

Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review.

Galli G, Corrao G, Imbimbo M, Proto C, Signorelli D, Ganzinelli M, Zilembo N, Vitali M, de Braud F, Garassino MC, Lo Russo G.

Lung Cancer. 2018 Jan;115:135-142. doi: 10.1016/j.lungcan.2017.12.002. Epub 2017 Dec 5. Review.

PMID:
29290256
7.

Concomitant EML4-ALK rearrangement and EGFR mutation in non-small cell lung cancer patients: a literature review of 100 cases.

Lo Russo G, Imbimbo M, Corrao G, Proto C, Signorelli D, Vitali M, Ganzinelli M, Botta L, Zilembo N, de Braud F, Garassino MC.

Oncotarget. 2017 Apr 26;8(35):59889-59900. doi: 10.18632/oncotarget.17431. eCollection 2017 Aug 29. Review.

8.

Cognitive impairment and chemotherapy: a brief overview.

Vitali M, Ripamonti CI, Roila F, Proto C, Signorelli D, Imbimbo M, Corrao G, Brissa A, Rosaria G, de Braud F, Garassino MC, Lo Russo G.

Crit Rev Oncol Hematol. 2017 Oct;118:7-14. doi: 10.1016/j.critrevonc.2017.08.001. Epub 2017 Aug 14. Review.

PMID:
28917271
9.

Treatment in EGFR-mutated non-small cell lung cancer: how to block the receptor and overcome resistance mechanisms.

Proto C, Lo Russo G, Corrao G, Ganzinelli M, Facchinetti F, Minari R, Tiseo M, Garassino MC.

Tumori. 2017 Jul 31;103(4):325-337. doi: 10.5301/tj.5000663. Epub 2017 Jul 1. Review.

PMID:
28708233
10.

[The slow acceptance of new oral anticoagulants in Italy: a critical analysis of a problem].

Botto GL, Cuccia C, Gronda E, Lombardi F, Lunati M, Maggi A, Massari FM, Musumeci G, Oliva F, Visconti LO, Proto C, Pusineri E, Ageno W.

G Ital Cardiol (Rome). 2017 Mar;18(3):208-218. doi: 10.1714/2674.27398. Review. Italian.

PMID:
28398379
11.

Mechanisms of Resistance to Target Therapies in Non-small Cell Lung Cancer.

Facchinetti F, Proto C, Minari R, Garassino M, Tiseo M.

Handb Exp Pharmacol. 2018;249:63-89. doi: 10.1007/164_2017_16.

PMID:
28332047
12.

Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of central nervous system metastases from non-small cell lung cancer: the present and the future.

Proto C, Imbimbo M, Gallucci R, Brissa A, Signorelli D, Vitali M, Macerelli M, Corrao G, Ganzinelli M, Greco FG, Garassino MC, Lo Russo G.

Transl Lung Cancer Res. 2016 Dec;5(6):563-578. doi: 10.21037/tlcr.2016.10.16. Review.

13.

Low AMH levels as a marker of reduced ovarian reserve in young women affected by Down's syndrome.

Romualdi D, Proto C, De Cicco S, Immediata V, Barone C, Romano C, Lanzone A.

Menopause. 2016 Nov;23(11):1247-1251.

PMID:
27465716
14.

Peptide receptor radionuclide therapy: focus on bronchial neuroendocrine tumors.

Lo Russo G, Pusceddu S, Prinzi N, Imbimbo M, Proto C, Signorelli D, Vitali M, Ganzinelli M, Maccauro M, Buzzoni R, Seregni E, de Braud F, Garassino MC.

Tumour Biol. 2016 Oct;37(10):12991-13003. Epub 2016 Jul 27. Review.

PMID:
27460087
15.

Small-Cell Lung Cancer: Clinical Management and Unmet Needs New Perspectives for an Old Problem.

Lo Russo G, Macerelli M, Platania M, Zilembo N, Vitali M, Signorelli D, Proto C, Ganzinelli M, Gallucci R, Agustoni F, Fasola G, de Braud F, Garassino MC.

Curr Drug Targets. 2017;18(3):341-362. doi: 10.2174/1389450117666160502152331. Review.

PMID:
27138756
16.

Deciphering intra-tumor heterogeneity of lung adenocarcinoma confirms that dominant, branching, and private gene mutations occur within individual tumor nodules.

Pelosi G, Pellegrinelli A, Fabbri A, Tamborini E, Perrone F, Settanni G, Busico A, Picciani B, Testi MA, Militti L, Maisonneuve P, Valeri B, Sonzogni A, Proto C, Garassino M, De Braud F, Pastorino U.

Virchows Arch. 2016 Jun;468(6):651-62. doi: 10.1007/s00428-016-1931-z. Epub 2016 Apr 7.

PMID:
27056568
17.

[The Italian Survey on Cardiac Rehabilitation - 2013 (ISYDE.13-Directory): national availability and organization of cardiac rehabilitation facilities].

Griffo R, Tramarin R, Volterrani M, Ambrosetti M, Caiazza F, Chimini C, Favretto G, Febo O, Gabriele M, Pusineri E, Greco C, Proto C; Società Italiana Cardiologia Ospedalita Accreditata.

G Ital Cardiol (Rome). 2016 Mar;17(3):217-24. doi: 10.1714/2190.23666. Italian.

PMID:
27029880
18.

Afatinib in the treatment of squamous non-small cell lung cancer: a new frontier or an old mistake?

Lo Russo G, Proto C, Garassino MC.

Transl Lung Cancer Res. 2016 Feb;5(1):110-4. doi: 10.3978/j.issn.2218-6751.2015.12.02.

19.

Treatment of lung large cell neuroendocrine carcinoma.

Lo Russo G, Pusceddu S, Proto C, Macerelli M, Signorelli D, Vitali M, Ganzinelli M, Gallucci R, Zilembo N, Platania M, Buzzoni R, de Braud F, Garassino MC.

Tumour Biol. 2016 Jun;37(6):7047-57. doi: 10.1007/s13277-016-5003-4. Epub 2016 Mar 4. Review.

PMID:
26943800
20.

Diagnosis and management of typical and atypical lung carcinoids.

Pusceddu S, Lo Russo G, Macerelli M, Proto C, Vitali M, Signorelli D, Ganzinelli M, Scanagatta P, Duranti L, Trama A, Buzzoni R, Pelosi G, Pastorino U, de Braud F, Garassino MC.

Crit Rev Oncol Hematol. 2016 Apr;100:167-76. doi: 10.1016/j.critrevonc.2016.02.009. Epub 2016 Feb 18. Review.

PMID:
26917456
21.

Incidence and clinical presentation of myocardial ischemia in patients with chronic CAD in Italy: the ISPICA survey study.

Volterrani M, Iellamo F, Marazzi G, Pusineri E, Guarini P, Bonassi S, Caiazza F, Tramarin R, Chimini C, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators.

J Cardiovasc Med (Hagerstown). 2016 Sep;17(9):647-52. doi: 10.2459/JCM.0000000000000345.

PMID:
26702596
22.

Systemic approach to malignant pleural mesothelioma: what news of chemotherapy, targeted agents and immunotherapy?

Signorelli D, Macerelli M, Proto C, Vitali M, Cona MS, Agustoni F, Zilembo N, Platania M, Trama A, Gallucci R, Ganzinelli M, Pelosi G, Pastorino U, de Braud F, Garassino MC, Lo Russo G.

Tumori. 2016 Jan-Feb;102(1):18-30. doi: 10.5301/tj.5000436. Epub 2015 Oct 14. Review.

PMID:
26481865
23.

Uncommon breast metastatic site and eribulin responsiveness in a heavily pretreated patient.

Ricciardi GR, Proto C, Ferraro G, Adamo V.

Future Oncol. 2014 Dec;10(15):2417-22. doi: 10.2217/fon.14.160.

PMID:
25525850
24.

ISMAR-study presentation: in-hospital epidemiology and clinical management of respiratory and cardiac comorbidities in cardiac and respiratory disease units.

Tramarin R, Polverino M, Volterrani M, Girardi B, Chimini C, Ambrosino N, De Benedetto F, Proto C.

Multidiscip Respir Med. 2014 May 20;9(1):28. doi: 10.1186/2049-6958-9-28. eCollection 2014.

25.

Anticoagulation in "real world" patients with atrial fibrillation in Italy: results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study.

Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini C, Zaccà F, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators.

Int J Cardiol. 2013 Oct 12;168(5):4729-33. doi: 10.1016/j.ijcard.2013.07.169. Epub 2013 Jul 26.

PMID:
23948115
26.

On-target antihypertensive treatment in Italy: the ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study.

Volterrani M, Iellamo F, Rosano G, Guarini P, Pusineri E, Bonassi S, Chimini C, Zaccà F, Proto C; SICOA (Società Italiana Cardiologia Ospedalità Accreditata) Investigators.

Int J Cardiol. 2013 Oct 9;168(4):4403-5. doi: 10.1016/j.ijcard.2013.05.040. Epub 2013 Jun 6. No abstract available.

PMID:
23746462
27.

[Atrial fibrillation and new oral anticoagulants: a therapeutic revolution?].

Di Pasquale G, Proto C, Riva L.

G Ital Cardiol (Rome). 2013 Mar;14(3 Suppl 1):69-75. doi: 10.1714/1261.13945. Italian.

PMID:
23612219
28.

Activity of pegylated liposomal doxorubicin in combination with gemcitabine in triple negative breast cancer with skin involvement: two case reports.

Franchina T, Adamo B, Ricciardi GR, Caristi N, Agostino RM, Proto C, Adamo V.

Cancer Biol Ther. 2012 May;13(7):472-6. doi: 10.4161/cbt.19593. Epub 2012 May 1.

PMID:
22526226
29.

The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome.

Romualdi D, De Cicco S, Tagliaferri V, Proto C, Lanzone A, Guido M.

J Clin Endocrinol Metab. 2011 May;96(5):E821-4. doi: 10.1210/jc.2010-1725. Epub 2011 Feb 9.

PMID:
21307134
30.

Implementation of cardiovascular secondary prevention guidelines in clinical practice: a nationwide survey in Italy.

Perrone-Filardi P, Poli A, Ambrosio G, Proto C, Chimini C, Chiariello M.

Nutr Metab Cardiovasc Dis. 2012 Feb;22(2):149-53. doi: 10.1016/j.numecd.2010.05.009. Epub 2010 Sep 28.

PMID:
20875948
31.

Fasting and post-methionine homocysteine levels in Alzheimers disease and vascular dementia.

Villa P, Bosco P, Ferri R, Perri C, Suriano R, Costantini B, Macrì F, Proto C, Cento RM, Lanzone A.

Int J Vitam Nutr Res. 2009 May;79(3):166-72. doi: 10.1024/0300-9831.79.3.166.

PMID:
20209467
32.

Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.

Romualdi D, De Marinis L, Campagna G, Proto C, Lanzone A, Guido M.

Clin Endocrinol (Oxf). 2008 Oct;69(4):562-7. doi: 10.1111/j.1365-2265.2008.03204.x. Epub 2008 Jan 31.

PMID:
18248643
33.

Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome.

Romualdi D, Campagna G, Selvaggi L Jr, Cento R, Proto C, Lanzone A, Guido M.

Fertil Steril. 2008 May;89(5):1273-6. Epub 2007 Jul 20.

PMID:
17658527
34.

Free and total leptin serum levels and soluble leptin receptors levels in two models of genetic obesity: the Prader-Willi and the Down syndromes.

Proto C, Romualdi D, Cento RM, Romano C, Campagna G, Lanzone A.

Metabolism. 2007 Aug;56(8):1076-80.

PMID:
17618952
35.

Association of thyroid dysfunction with vitamin B12, folate and plasma homocysteine levels in the elderly: a population-based study in Sicily.

Stella G, Spada RS, Calabrese S, Bosco P, Anello G, Guéant-Rodriguez RM, Romano A, Benamghar L, Proto C, Castellano A, Fajardo A, Lipari L, Sirna S, Guéant JL.

Clin Chem Lab Med. 2007;45(2):143-7.

PMID:
17311498
36.

Plasma levels of neuropeptides in Alzheimer's disease.

Proto C, Romualdi D, Cento RM, Spada RS, Di Mento G, Ferri R, Lanzone A.

Gynecol Endocrinol. 2006 Apr;22(4):213-8.

PMID:
16723308
37.

[Cardiological protocols on evaluation of fitness for competitive sports].

Delise P, Guiducci U, Zeppilli P, D'Andrea L, Proto C, Bettini R, Villella A, Caselli G, Giada F, Pelliccia A, Penco M, Thiene G, Notaristefano A, Spataro A; Società Italiana di Cardiologia dello Sport; Associazione Nazionale Cardiologi Extraospedalieri; Associazione Nazionale Medici Cardiologi Ospedalieri; Federazione Medico Sportiva Italiana; Società Italiana di Cardiologia.

Ital Heart J Suppl. 2005 Aug;6(8):502-46. Italian. No abstract available.

PMID:
16161505
38.

Cardiological guidelines for competitive sports eligibility.

Delise P, Guiducci U, Zeppilli P, D'Andrea L, Proto C, Bettini R, Villella A, Caselli G, Giada F, Pelliccia A, Penco M, Thiene G, Notaristefano A, Spataro A; Italian Society of Sports Cardiology; Italian Association of Out-of-Hospital Cardiologists; Italian Association of Hospital Cardiologists; Italian Federation of Sports Medicine.

Ital Heart J. 2005 Aug;6(8):661-702. No abstract available.

PMID:
16161501
39.

Twenty-four-hour urinary cortisol levels in Alzheimer disease and in dysthymia.

Spada RS, Cento RM, Proto C, Magiafico RA, Cosentino FI, Ferri R, Iero I, Lanuzza B, Toscano G, Tripodi M, Lanzone A.

Arch Gerontol Geriatr Suppl. 2002;8:353-8. No abstract available.

PMID:
14764415
40.

[Reply to "Open letter to Italian cardiologists. An invitation to debate" (Ital Heart J Suppl 2003, 4(4): 271-6)].

Proto C.

Ital Heart J Suppl. 2003 Jul;4(7):608-9. Italian. No abstract available.

PMID:
14558291
41.

Twenty-four-hour urinary cortisol levels in Alzheimer disease and in mild cognitive impairment.

Spada RS, Cento RM, Proto C, Cosentino FI, Ferri R, Iero I, Lanuzza B, Mangiafico RA, Toscano G, Tripodi M, Lanzone A.

J Endocrinol Invest. 2002;25(10 Suppl):78-80. No abstract available.

PMID:
12508927
42.

Neuroendocrine features of pubertal development in females with mental retardation.

Cento RM, Ciampelli M, Proto C, Le Donne M, Romano C, Lanzone A.

Gynecol Endocrinol. 2001 Jun;15(3):178-83.

PMID:
11447728
43.

Twenty-four-hour urinary free cortisol levels in vascular dementia and in Alzheimer's disease.

Spada RS, Cento RM, Proto C, Ferri R, Roccasalva G, Toscano G, Cosentino FI, Lanzone A.

Arch Gerontol Geriatr Suppl. 2001;7:363-7. No abstract available.

PMID:
11431087
44.

Postmenarchal Down's syndrome: a theoretical model of growth hormone action on ovarian function.

Cento RM, Proto C, Guido M, Lanzone A.

Gynecol Endocrinol. 2001 Feb;15(1):81-8. Review.

PMID:
11293930
45.

Stromal-epithelial interactions modulate estrogen responsiveness in normal human endometrium.

Pierro E, Minici F, Alesiani O, Miceli F, Proto C, Screpanti I, Mancuso S, Lanzone A.

Biol Reprod. 2001 Mar;64(3):831-8.

PMID:
11207198
46.

Endothelins enhance prostaglandin (PGE(2) and PGF(2alpha)) biosynthesis and release by human luteal cells: evidence of a new paracrine/autocrine regulation of luteal function.

Miceli F, Minici F, Garcia Pardo M, Navarra P, Proto C, Mancuso S, Lanzone A, Apa R.

J Clin Endocrinol Metab. 2001 Feb;86(2):811-7.

PMID:
11158051
47.

Leptin levels in menopause: effect of estrogen replacement therapy.

Cento RM, Proto C, Spada RS, Napolitano V, Ciampelli M, Cucinelli F, Lanzone A.

Horm Res. 1999;52(6):269-73.

PMID:
10965205
48.

Growth hormone, Alzheimer's disease and normal aging in the oldest old subjects.

Spada RS, Ferri R, Proto C, Roccasalva G, Toscano G, Cento RM, Cosentino FI, Mangiafico RA.

J Endocrinol Invest. 1999;22(10 Suppl):55-6. No abstract available.

PMID:
10727045
49.

Serum leptin concentrations in obese women with Down syndrome and Prader-Willi syndrome.

Cento RM, Proto C, Spada RS, Ragusa L, Reitano S, Napolitano V, Lanzone A.

Gynecol Endocrinol. 1999 Feb;13(1):36-41.

PMID:
10368796
50.

IGF-I levels in prepubertal and pubertal children with Down syndrome.

Ragusa L, Valetto MR, Proto C, Alberti A, Romano C, Rossodivita A, Corneli G, Baffoni C, Lanfranco F, Aimaretti G, Colabucci F, Ghigo E.

Minerva Endocrinol. 1998 Jun;23(2):31-6.

PMID:
9844353

Supplemental Content

Support Center